高级检索
当前位置: 首页 > 详情页

Methyl 3,4-Dihydroxybenzoate Induces Neural Stem Cells to Differentiate Into Cholinergic Neurons in vitro.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Pharmacology, College of Basic Medicine, Jinan University, Guangzhou, China, [2]Department of Neurosurgery, Guangzhou Women and Children’s Medical Center, Guangzhou, China, [3]Institute of Brain Sciences, Jinan University, Guangzhou, China, [4]Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, China, [5]Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Sciences, Sun Yat-sen University, Guangzhou, China
出处:
ISSN:

关键词: methyl 3 4-dihydroxybenzoate neural stem cells differentiate cholinergic neurons GSK3b cell cycle Isl1

摘要:
Neural stem cells (NSCs) have been shown as a potential source for replacing degenerated neurons in neurodegenerative diseases. However, the therapeutic potential of these cells is limited by the lack of effective methodologies for controlling their differentiation. Inducing endogenous pools of NSCs by small molecule can be considered as a potential approach of generating the desired cell types in large numbers. Here, we reported the characterization of a small molecule (Methyl 3,4-dihydroxybenzoate; MDHB) that selectively induces hippocampal NSCs to differentiate into cholinergic motor neurons which expressed synapsin 1 (SYN1) and postsynaptic density protein 95 (PSD-95). Studies on the mechanisms revealed that MDHB induced the hippocampal NSCs differentiation into cholinergic motor neurons by inhibiting AKT phosphorylation and activating autophosphorylation of GSK3β at tyrosine 216. Furthermore, we found that MDHB enhanced β-catenin degradation and abolished its entering into the nucleus. Collectively, this report provides the strong evidence that MDHB promotes NSCs differentiation into cholinergic motor neurons by enhancing gene Isl1 expression and inhibiting cell cycle progression. It may provide a basis for pharmacological effects of MDHB directed on NSCs.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 神经科学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 神经科学
JCR分区:
出版当年[2016]版:
Q1 NEUROSCIENCES
最新[2023]版:
Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Pharmacology, College of Basic Medicine, Jinan University, Guangzhou, China, [2]Department of Neurosurgery, Guangzhou Women and Children’s Medical Center, Guangzhou, China,
共同第一作者:
通讯作者:
通讯机构: [1]Department of Pharmacology, College of Basic Medicine, Jinan University, Guangzhou, China, [3]Institute of Brain Sciences, Jinan University, Guangzhou, China,
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号